Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Andrew D Vonberg"'
Autor:
Esam S. B. Salem, Andrew D. Vonberg, Vishnupriya J. Borra, Rupinder K. Gill, Takahisa Nakamura
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 6 (2019)
The increasing prevalence of worldwide obesity has emerged as a major risk factor for type 2 diabetes (T2D), hepatosteatosis, and cardiovascular disease. Accumulating evidence indicates that obesity has strong inflammatory underpinnings tightly linke
Externí odkaz:
https://doaj.org/article/e6e120749b454fafab437a887004aaf3
Autor:
Liping Yu, Michael P. Morran, Dorothy J. Becker, Howard W. Davidson, Shuai Huang, Andrew D Vonberg, Massimo Pietropaolo, Charles F. Verge, Roberto Gianani, Maria Acevedo-Calado, Susan L. Pietropaolo, Stephen S. Rich, Carla J. Greenbaum, Santiago Schnell, Aaron W. Michels
Publikováno v:
Diabetes
We identified autoantibodies (AAb) reacting with a variant IA-2 molecule (IA-2var) that has three amino acid substitutions (Cys27, Gly608, and Pro671) within the full-length molecule. We examined IA-2var AAb in first-degree relatives of type 1 diabet
Autor:
Andrew D. Vonberg, Massimo Pietropaolo
Publikováno v:
Diabetes. 67
We describe a protective effect on autoimmune diabetes and a reduced destructive insulitis in NOD.scid recipients following splenocyte injections from diabetic NOD donors and sorted CD19+ cells compared to NOD.scid recipients receiving splenocytes al
Autor:
Massimo Pietropaolo, Steven K. Lundy, Aaron R. Cox, Andrew D. Vonberg, Maria Acevedo-Calado, Roberto Gianani, Susan L. Pietropaolo
Publikováno v:
JCI insight. 3(23)
We describe a protective effect on autoimmune diabetes and reduced destructive insulitis in NOD.scid recipients following splenocyte injections from diabetic NOD donors and sorted CD19+ cells compared with NOD.scid recipients receiving splenocytes al
Publikováno v:
Molecular aspects of medicine. 42
Type 1 diabetes mellitus (T1DM) is an autoimmune disease arising through a complex interaction of both genetic and immunologic factors. Similar to the majority of autoimmune diseases, T1DM usually has a relapsing remitting disease course with autoant